146 related articles for article (PubMed ID: 35469182)
1. Nonadherence to Multimodality Cancer Treatment Guidelines in the United States.
Tchelebi LT; Shen B; Wang M; Potters L; Herman J; Boffa D; Segel JE; Park HS; Zaorsky NG
Adv Radiat Oncol; 2022; 7(5):100938. PubMed ID: 35469182
[TBL] [Abstract][Full Text] [Related]
2. Black and Hispanic women are less likely than white women to receive guideline-concordant endometrial cancer treatment.
Kaspers M; Llamocca E; Quick A; Dholakia J; Salani R; Felix AS
Am J Obstet Gynecol; 2020 Sep; 223(3):398.e1-398.e18. PubMed ID: 32142825
[TBL] [Abstract][Full Text] [Related]
3. Racial Disparities in Receipt of Guideline-Concordant Care for Early-Onset Colorectal Cancer in the United States.
Nogueira LM; May FP; Yabroff KR; Siegel RL
J Clin Oncol; 2024 Apr; 42(12):1368-1377. PubMed ID: 37939323
[TBL] [Abstract][Full Text] [Related]
4. Guideline-concordant endometrial cancer treatment and survival in the Women's Health Initiative Life and Longevity After Cancer study.
Felix AS; McLaughlin EM; Caan BJ; Cohn DE; Anderson GL; Paskett ED
Int J Cancer; 2020 Jul; 147(2):404-412. PubMed ID: 31618444
[TBL] [Abstract][Full Text] [Related]
5. Guideline-concordant Care Improves Overall Survival for Locally Advanced Non-Small-cell Lung Carcinoma Patients: A National Cancer Database Analysis.
Ahmed HZ; Liu Y; O'Connell K; Ahmed MZ; Cassidy RJ; Gillespie TW; Patel P; Pillai RN; Behera M; Steuer CE; Owonikoko TK; Ramalingam SS; Curran WJ; Higgins KA
Clin Lung Cancer; 2017 Nov; 18(6):706-718. PubMed ID: 28601387
[TBL] [Abstract][Full Text] [Related]
6. Factors Associated With Guideline-Concordant Pharmacological Treatment for Neuropathic Pain Among Breast Cancer Survivors.
Lakkad M; Martin B; Li C; Harrington S; Dayer L; Painter JT
Clin Breast Cancer; 2023 Aug; 23(6):598-619. PubMed ID: 37328334
[TBL] [Abstract][Full Text] [Related]
7. Racial disparities in guideline-concordant cancer care and mortality in the United States.
Fang P; He W; Gomez D; Hoffman KE; Smith BD; Giordano SH; Jagsi R; Smith GL
Adv Radiat Oncol; 2018; 3(3):221-229. PubMed ID: 30202793
[TBL] [Abstract][Full Text] [Related]
8. Evaluating the urban-rural paradox: The complicated relationship between distance and the receipt of guideline-concordant care among cervical cancer patients.
Spees LP; Wheeler SB; Varia M; Weinberger M; Baggett CD; Zhou X; Petermann VM; Brewster WR
Gynecol Oncol; 2019 Jan; 152(1):112-118. PubMed ID: 30442384
[TBL] [Abstract][Full Text] [Related]
9. Predictors of Nonadherence to NCCN Guideline Recommendations for the Management of Stage I Anal Canal Cancer.
Kole AJ; Stahl JM; Park HS; Khan SA; Johung KL
J Natl Compr Canc Netw; 2017 Mar; 15(3):355-362. PubMed ID: 28275036
[No Abstract] [Full Text] [Related]
10. Sociodemographic and Facility-Related Disparities in the Delivery of Guideline-Concordant Therapy Among Patients With Esophageal Adenocarcinoma.
da Costa WL; Camp ER; Thrift AP
JCO Oncol Pract; 2022 Jul; 18(7):e1181-e1197. PubMed ID: 35436147
[TBL] [Abstract][Full Text] [Related]
11. Survival rates in Hispanic/Latinx subpopulations with cervical cancer associated with disparities in guideline-concordant care.
Dinicu AI; Dioun S; Wang Y; Huang Y; Wright JD; Tergas AI
Gynecol Oncol; 2024 Feb; 184():214-223. PubMed ID: 38340647
[TBL] [Abstract][Full Text] [Related]
12. Guideline-concordant timely lung cancer care and prognosis among elderly patients in the United States: A population-based study.
Nadpara P; Madhavan SS; Tworek C
Cancer Epidemiol; 2015 Dec; 39(6):1136-44. PubMed ID: 26138902
[TBL] [Abstract][Full Text] [Related]
13. Association of guideline-concordant initial systemic treatment with clinical and economic outcomes among older women with metastatic breast cancer in the United States.
Vyas A; Mantaian T; Kamat S; Kurian S; Kogut S
J Geriatr Oncol; 2021 Sep; 12(7):1092-1099. PubMed ID: 34099411
[TBL] [Abstract][Full Text] [Related]
14. Influence of Age on Guideline-Concordant Cancer Care for Elderly Patients in the United States.
Fang P; He W; Gomez DR; Hoffman KE; Smith BD; Giordano SH; Jagsi R; Smith GL
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):748-757. PubMed ID: 28366580
[TBL] [Abstract][Full Text] [Related]
15. The Relative Survival Impact of Guideline-Concordant Clinical Staging and Stage-Appropriate Treatment of Potentially Curable Non-Small Cell Lung Cancer.
Meadows-Taylor MB; Faris NR; Smeltzer MP; Ray MA; Fehnel C; Akinbobola O; Ariganjoye F; Patel A; Pacheco A; Mehrotra A; Fox R; Optican R; Tonkin K; Machin J; Wright J; Robbins ET; Osarogiagbon RU
Chest; 2022 Jul; 162(1):242-255. PubMed ID: 35122751
[TBL] [Abstract][Full Text] [Related]
16. Guideline-Concordant Treatment Among Elderly Women With HER2-Positive Metastatic Breast Cancer in the United States.
Vyas AM; Aroke H; Kogut S
J Natl Compr Canc Netw; 2020 Apr; 18(4):405-413. PubMed ID: 32259787
[TBL] [Abstract][Full Text] [Related]
17. Disparities in guideline-concordant treatment for node-positive, non-small cell lung cancer following surgery.
Farrow NE; An SJ; Speicher PJ; Harpole DH; D'Amico TA; Klapper JA; Hartwig MG; Tong BC
J Thorac Cardiovasc Surg; 2020 Jul; 160(1):261-271.e1. PubMed ID: 31924363
[TBL] [Abstract][Full Text] [Related]
18. Guideline-concordant cancer care and survival among American Indian/Alaskan Native patients.
Javid SH; Varghese TK; Morris AM; Porter MP; He H; Buchwald D; Flum DR;
Cancer; 2014 Jul; 120(14):2183-90. PubMed ID: 24711210
[TBL] [Abstract][Full Text] [Related]
19. Clinical-Pathologic Correlation and Guideline Concordance in Resectable Non-Small Cell Lung Cancer.
Stokes SM; Massarweh NN; Stringham JR; Varghese TK
Ann Thorac Surg; 2019 Sep; 108(3):837-844. PubMed ID: 31026431
[TBL] [Abstract][Full Text] [Related]
20. Insurance-Based Disparities in Guideline-Concordant Thyroid Cancer Care in the Era of De-escalation.
Ginzberg SP; Soegaard Ballester JM; Wirtalla CJ; Pryma DA; Mandel SJ; Kelz RR; Wachtel H
J Surg Res; 2023 Sep; 289():211-219. PubMed ID: 37141704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
